Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients

International Journal of Cardiology

Volumn 173, Issue 1, 2014, Pages 120-121

  Gaubert, Melanie ^a   Laine, Marc ^a   Richard, Toesca ^b   Fournier, Nathalie ^b   Gramond, Christophe ^c   Bessereau, Jacques ^b   Mokrani, Zaïr ^d   Bultez, Bruno ^e   Chelini, Virginie ^f   Barnay, Pierre ^g   Maillard, Luc ^h   Paganelli, Franck ^a   Bonello, Laurent ^a  

^a HÔPITAL NORD   (France)

^b North Hospital   (France)

^c HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^d Centre Hospitalier de Salon de Provence   (France)

^e Hôpital de Sisteron   (France)

^f Hopital de Martigues   (France)

^g Hôpital d'Avignon   (France)

^h Clinique Axium   (France)

Author keywords

Acute coronary syndrome; Compliance; Dyspnea; Side effects; Ticagrelor

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICAGRELOR; ADENOSINE; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ADULT; BLEEDING; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY FAILURE; LETTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNSTABLE ANGINA PECTORIS; AGED; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; FOLLOW UP; MEDICATION COMPLIANCE; MIDDLE AGED; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADENOSINE; AGED; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; TREATMENT OUTCOME;

EID: 84897382642     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.02.028     Document Type: Article

References (10)

1. S. Yusuf, F. Zhao, and S.R. Mehta et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
2. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
3. L. Wallentin, R.C. Becker, and A. Budaj et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
4. R.F. Storey, R.C. Becker, and R.A. Harrington et al. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy) Am J Cardiol 108 2011 1542 1546
5. R.F. Storey, R.C. Becker, and R.A. Harrington et al. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes Eur Heart J 32 2011 2945 2953
6. L. Bonello, M. Laine, and N. Kipson et al. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome J Am Coll Cardiol 63 9 2014 872 877
7. M. Cattaneo, and E.M. Faioni Why does ticagrelor induce dyspnea? Thromb Haemost 108 2012 1031 1036
8. V.L. Serebruany Viewpoint: reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel Thromb Haemost 108 2012 1024 1027
9. R. Mehran, U. Baber, and P.G. Steg et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study Lancet 382 2013 1714 1722
10. I. Iakovou, T. Schmidt, and E. Bonizzoni et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130